Your browser doesn't support javascript.
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
Arndt, Volker; Doege, Daniela; Fröhling, Stefan; Albers, Peter; Algül, Hana; Bargou, Ralf; Bokemeyer, Carsten; Bornhäuser, Martin; Brandts, Christian H; Brossart, Peter; Brucker, Sara Yvonne; Brümmendorf, Tim H; Döhner, Hartmut; Gattermann, Norbert; Hallek, Michael; Heinemann, Volker; Keilholz, Ulrich; Kindler, Thomas; von Levetzow, Cornelia; Lordick, Florian; Neumann, Ulf Peter; Peters, Christoph; Schadendorf, Dirk; Stilgenbauer, Stephan; Zander, Thomas; Zips, Daniel; Braun, Delia; Seufferlein, Thomas; Nettekoven, Gerd; Baumann, Michael.
  • Arndt V; Division of Clinical Epidemiology and Aging Research (C070), Unit of Cancer Survivorship (C071), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. v.arndt@dkfz-heidelberg.de.
  • Doege D; Division of Clinical Epidemiology and Aging Research (C070), Unit of Cancer Survivorship (C071), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Albers P; Department of Urology, Comprehensive Cancer Center/Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Medical Faculty of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Algül H; Comprehensive Cancer Center TUM (CCCMTUM), Klinikum Rechts der Isar of the Technical University of Munich, Munich, Germany.
  • Bargou R; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
  • Bokemeyer C; Medical Clinic and Polyclinic II, Center for Oncology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bornhäuser M; Medical Clinic I, National Center for Tumor Diseases (NCT/UCC), University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany.
  • Brandts CH; University Cancer Center (UCT) Frankfurt-Marburg, Frankfurt University Hospital, Frankfurt, Germany.
  • Brossart P; Medical Clinic III and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Bonn, Bonn, Germany.
  • Brucker SY; Comprehensive Cancer Center Tübingen-Stuttgart and Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
  • Brümmendorf TH; Medical Clinic IV and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital of RWTH Aachen, Aachen, Germany.
  • Döhner H; Comprehensive Cancer Center Ulm (CCCU) and Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Gattermann N; Department of Hematology, Oncology and Clinical Immunology, Comprehensive Cancer Center/Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Medical Faculty of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Hallek M; Clinic I for Internal Medicine and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Cologne, Cologne, Germany.
  • Heinemann V; Medical Clinic and Polyclinic III, LMU Hospital, Munich, Germany.
  • Keilholz U; Charité Comprehensive Cancer Center (CCCC), Berlin, Germany.
  • Kindler T; University Cancer Center (UCT), University Medical Center Mainz, Mainz, Germany.
  • von Levetzow C; Clinic I for Internal Medicine and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Cologne, Cologne, Germany.
  • Lordick F; University Cancer Center Leipzig and Department of Medicine II, University of Leipzig Medical Center, Leipzig, Germany.
  • Neumann UP; Department of Visceral and Transplantation Surgery, University Hospital of RWTH Aachen, Aachen, Germany.
  • Peters C; Tumor Center Freiburg, Institute of Molecular Medicine and Cell Research, Freiburg, Germany.
  • Schadendorf D; West German Tumor Center (WTZ) Essen and Clinic for Dermatology, Essen University Hospital, Essen, Germany.
  • Stilgenbauer S; Comprehensive Cancer Center Ulm (CCCU) and Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Zander T; Clinic I for Internal Medicine and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Cologne, Cologne, Germany.
  • Zips D; Comprehensive Cancer Center Tübingen-Stuttgart and Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Braun D; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Seufferlein T; German Cancer Society, Berlin, Germany.
  • Nettekoven G; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
  • Baumann M; German Cancer Aid, Bonn, Germany.
J Cancer Res Clin Oncol ; 2022 Oct 14.
Article in English | MEDLINE | ID: covidwho-2250217
ABSTRACT

PURPOSE:

An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.

METHODS:

Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.

RESULTS:

The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.

CONCLUSIONS:

This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research Language: English Year: 2022 Document Type: Article Affiliation country: S00432-022-04407-1

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research Language: English Year: 2022 Document Type: Article Affiliation country: S00432-022-04407-1